http://www.advfn.com/nyse/rss.asp?symbol=NVS Novartis Company Newsfeed en Mon, 20 May 2013 06:52:34 EDT Mon, 20 May 2013 06:52:34 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=NVS&article=57643627&headline=affymetrix-names-gavin-wood-chief-financial-officer http://www.advfn.com/nyse/StockNews.asp?stocknews=NVS&article=57643627&headline=affymetrix-names-gavin-wood-chief-financial-officer <div class='newsbody'><pre> By Melodie Warner </pre> <p> Affymetrix Inc. (AFFX) named Gavin Wood chief financial officer and executive vice president to succeed Tim Barabe, who intends to retire June 28. </p> <p> Mr. Wood joined Affymetrix in 2006 and most recently served as vice president of finance... Mon, 20 May 2013 06:52:34 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=NVS&article=57595212&headline=novartis-considers-possible-bid-for-actavis http://www.advfn.com/nyse/StockNews.asp?stocknews=NVS&article=57595212&headline=novartis-considers-possible-bid-for-actavis <div class='newsbody'><p> A heated takeover battle has erupted around generic-drug company Actavis Inc. (ACT) as industry players seek to shore themselves up amid increasing competition and fewer new knock-off-drug opportunities. </p> <p> Valeant Pharmaceuticals International Inc. (VRX, VRX.T) and Mylan... Wed, 15 May 2013 19:00:14 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=NVS&article=57524632&headline=correction-to-story-on-novartiss-fda-approval-for-ilaris http://www.advfn.com/nyse/StockNews.asp?stocknews=NVS&article=57524632&headline=correction-to-story-on-novartiss-fda-approval-for-ilaris <div class='newsbody'><p> "Novartis: FDA Approves Ilaris for Serious Form of Childhood Arthritis," at 7:15 a.m. ET, misstated in the fourth paragraph the age indication for the latest FDA approval for Ilaris. The approval is for children aged two and older. </p> <p> Subscribe to WSJ: http://online.wsj.com?mod=djnwires... Fri, 10 May 2013 17:23:16 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=NVS&article=57513371&headline=novartis-fda-approves-ilaris-for-serious-form-of-childhood-arthritis http://www.advfn.com/nyse/StockNews.asp?stocknews=NVS&article=57513371&headline=novartis-fda-approves-ilaris-for-serious-form-of-childhood-arthritis <div class='newsbody'><pre> By Melodie Warner </pre> <p> Novartis AG (NVS, NOVN.VX) said the U.S. Food and Drug Administration approved Ilaris for the treatment of active systemic juvenile idiopathic arthritis, a serious form of childhood arthritis. </p> <p> SJIA affects fewer than one child in every... Fri, 10 May 2013 07:45:16 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=NVS&article=57452493&headline=endo-health-swings-to-first-quarter-profit-on-strong-generic http://www.advfn.com/nyse/StockNews.asp?stocknews=NVS&article=57452493&headline=endo-health-swings-to-first-quarter-profit-on-strong-generic <div class='newsbody'><pre> By Tess Stynes </pre> <p> Endo Health Solutions Inc. (ENDP) swung to a first-quarter profit amid fewer write-downs and other items, as well as a modest revenue increase as strong sales growth in its generic segment offset declines in other businesses. </p> <p> New Chief Executive... Tue, 07 May 2013 08:01:41 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=NVS&article=57380794&headline=auction-of-brazilian-drug-company-ache-stalls-on-differences http://www.advfn.com/nyse/StockNews.asp?stocknews=NVS&article=57380794&headline=auction-of-brazilian-drug-company-ache-stalls-on-differences <div class='newsbody'><pre> By Dana Cimilluca and Luciana Magalhaes </pre> <p> The auction of Ach&eacute; Laborat&oacute;rios Farmac&ecirc;uticos SA, which has drawn interest from some of the biggest names in the global healthcare industry, has stalled due to disagreement among the Brazilian drug company's... Tue, 30 Apr 2013 11:58:44 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=NVS&article=57344592&headline=u-s-sues-novartis-for-allegedly-paying-kickbacks http://www.advfn.com/nyse/StockNews.asp?stocknews=NVS&article=57344592&headline=u-s-sues-novartis-for-allegedly-paying-kickbacks <div class='newsbody'><p> Federal prosecutors accused Novartis Pharmaceuticals Corp. of paying kickbacks and providing lavish dinners to doctors to encourage them to prescribe the company's brand-name drugs to treat hypertension and other maladies. </p> <p> The payments were disguised as honorariums... Fri, 26 Apr 2013 15:50:18 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=NVS&article=57317666&headline=mixed-results-for-drug-companies http://www.advfn.com/nyse/StockNews.asp?stocknews=NVS&article=57317666&headline=mixed-results-for-drug-companies <div class='newsbody'><p> AstraZeneca PLC (AZN.LN) said Thursday profit and sales fell for a fifth-consecutive quarter as the drug giant continues to suffer patent expiries that leave some of its blockbuster products open to competition from generic brands. </p> <p> Also Thursday, Germany's Bayer AG... Thu, 25 Apr 2013 05:40:23 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=NVS&article=57301515&headline=novartis-boosted-by-drug-launches http://www.advfn.com/nyse/StockNews.asp?stocknews=NVS&article=57301515&headline=novartis-boosted-by-drug-launches <div class='newsbody'><p> ZURICH--Swiss drug maker Novartis AG (NOVN.VX) Wednesday posted a rise in first-quarter net profit, as new product launches and strength in emerging markets helped offset declining sales of the blockbuster heart drug Diovan. </p> <p> In an unexpected move, Novartis also said... Wed, 24 Apr 2013 06:50:15 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=NVS&article=57296195&headline=novartis-1q-net-profit-misses-expectations-new-products-deliver http://www.advfn.com/nyse/StockNews.asp?stocknews=NVS&article=57296195&headline=novartis-1q-net-profit-misses-expectations-new-products-deliver <div class='newsbody'><pre> By Marta Falconi </pre> <p> ZURICH--Swiss drug maker Novartis AG (NVS) on Wednesday posted a worse-than-expected first-quarter net profit. This is in spite of new product launches and sales in emerging markets offsetting weaker sales of a blockbuster heart drug. </p> <p> In... Wed, 24 Apr 2013 02:00:22 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=NVS&article=57296155&headline=u-s-accuses-novartis-of-kickbacks http://www.advfn.com/nyse/StockNews.asp?stocknews=NVS&article=57296155&headline=u-s-accuses-novartis-of-kickbacks <div class='newsbody'><p> Federal prosecutors accused Novartis Pharmaceuticals Corp. of paying kickbacks to get pharmacies to switch kidney-transplant patients from generic drugs to the company's brand-name product. </p> <p> In a civil-fraud lawsuit filed Tuesday in federal court in Manhattan, prosecutors... Wed, 24 Apr 2013 01:50:21 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=NVS&article=57295006&headline=u-s-accuses-novartis-of-paying-kickbacks-to-pharmacies-in-lawsuit http://www.advfn.com/nyse/StockNews.asp?stocknews=NVS&article=57295006&headline=u-s-accuses-novartis-of-paying-kickbacks-to-pharmacies-in-lawsuit <div class='newsbody'><pre> By Peter Loftus </pre> <p> The U.S. Justice Department has accused a Novartis AG (NVS) pharmaceutical division of providing kickbacks to pharmacies to switch patients to a Novartis drug used to prevent rejection of kidney transplants. </p> <p> The U.S. Attorney's office in... Tue, 23 Apr 2013 18:01:35 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=NVS&article=57276745&headline=anglo-american-shareholder-opposition-to-remuneration-report http://www.advfn.com/nyse/StockNews.asp?stocknews=NVS&article=57276745&headline=anglo-american-shareholder-opposition-to-remuneration-report <div class='newsbody'><p> By Alex MacDonald </p> <p> LONDON--The number of votes cast against globally diversified mining Anglo American PLC's (AAUKY, AAL.LN) remuneration report increased this year compared with last year, reflecting continued concerns about high-level-executive pay, data released by... Mon, 22 Apr 2013 17:31:18 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=NVS&article=57193768&headline=europe-markets-europe-stocks-extend-losses-to-third-day http://www.advfn.com/nyse/StockNews.asp?stocknews=NVS&article=57193768&headline=europe-markets-europe-stocks-extend-losses-to-third-day <div class='newsbody'><p> By Sara Sjolin, MarketWatch </p> <p> LONDON (MarketWatch) -- European stock markets extended losses into a third straight day on Tuesday, as concerns about global growth remained in the spotlight after Germany's ZEW index missed expectations. </p> <p> Most markets, however... Tue, 16 Apr 2013 12:27:18 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=NVS&article=57185692&headline=europe-markets-europe-stocks-hold-losses-after-german-zew http://www.advfn.com/nyse/StockNews.asp?stocknews=NVS&article=57185692&headline=europe-markets-europe-stocks-hold-losses-after-german-zew <div class='newsbody'><p> By Sara Sjolin, MarketWatch </p> <p> LONDON (MarketWatch) -- European stock markets were on track for a third straight day of losses on Tuesday, as concerns about global growth remained in the spotlight after Germany's ZEW index missed expectations. </p> <p> The Stoxx Europe... Tue, 16 Apr 2013 06:41:33 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=NVS&article=57171438&headline=europe-markets-europe-stocks-slide-after-china-gdp-miners-sink http://www.advfn.com/nyse/StockNews.asp?stocknews=NVS&article=57171438&headline=europe-markets-europe-stocks-slide-after-china-gdp-miners-sink <div class='newsbody'><p> By Sara Sjolin, MarketWatch </p> <p> LONDON (MarketWatch) -- European stock markets posted sharp losses on Monday, with miners leading the drive south as gold prices tanked and data showed China's economy grew more slowly than expected in the first quarter. </p> <p> The Stoxx... Mon, 15 Apr 2013 12:18:49 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=NVS&article=57160784&headline=europe-markets-europe-stocks-slide-after-china-gdp-miners-sink http://www.advfn.com/nyse/StockNews.asp?stocknews=NVS&article=57160784&headline=europe-markets-europe-stocks-slide-after-china-gdp-miners-sink <div class='newsbody'><p> By Sara Sjolin, MarketWatch </p> <p> LONDON (MarketWatch) -- European stock markets posted sharp losses on Monday, with miners leading the drive south after weaker-than-expected Chinese growth figures and slumping metals prices. </p> <p> The Stoxx Europe 600 index dropped 0.9... Mon, 15 Apr 2013 05:07:09 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=NVS&article=57145657&headline=portola-pharmaceuticals-files-plans-for-150-million-ipo http://www.advfn.com/nyse/StockNews.asp?stocknews=NVS&article=57145657&headline=portola-pharmaceuticals-files-plans-for-150-million-ipo <div class='newsbody'><pre> By Kristin Jones </pre> <p> Portola Pharmaceuticals has filed plans to raise up to $150 million through an initial public offering. </p> <p> The biopharmaceutical company focuses on developing treatments for blood disorders including thrombosis--when a blood clot forms inside... Fri, 12 Apr 2013 18:48:24 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=NVS&article=57013670&headline=merck-unit-sun-pharma-file-patent-suit-against-glenmark http://www.advfn.com/nyse/StockNews.asp?stocknews=NVS&article=57013670&headline=merck-unit-sun-pharma-file-patent-suit-against-glenmark <div class='newsbody'><p> By R. Jai Krishna </p> <p> NEW DELHI--Merck &amp; Co.'s (MRK) Indian unit and Sun Pharmaceutical Industries Ltd. (524715.BY) have filed a patent-infringement lawsuit against Glenmark Pharmaceuticals Ltd. (532296.BY) over an anti-diabetes drug. </p> <p> This is the latest among... Wed, 03 Apr 2013 12:10:06 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=NVS&article=56974717&headline=market-snapshot-u-s-stocks-retreat-after-manufacturing-data http://www.advfn.com/nyse/StockNews.asp?stocknews=NVS&article=56974717&headline=market-snapshot-u-s-stocks-retreat-after-manufacturing-data <div class='newsbody'><p> By Kate Gibson, MarketWatch </p> <p> NEW YORK (MarketWatch) -- U.S. stocks lost ground on Monday, with two benchmark indexes retreating from record highs after a closely watched manufacturing gauge unexpectedly fell in March. </p> <p> The Institute for Supply Management's factory... Mon, 01 Apr 2013 11:15:49 EDT